Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ADVANCED ENZYME TECHNOLOGIES vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ADVANCED ENZYME TECHNOLOGIES   ACTAVIS
EQUITY SHARE DATA
    ADVANCED ENZYME TECHNOLOGIES
Mar-23
ACTAVIS
Dec-18
ADVANCED ENZYME TECHNOLOGIES/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs32816,146-   
Low Rs22510,831-   
Sales per share (Unadj.) Rs48.33,960.5-  
Earnings per share (Unadj.) Rs9.3-1,275.7-  
Cash flow per share (Unadj.) Rs12.4417.4-  
Dividends per share (Unadj.) Rs5.000-  
Avg Dividend yield %1.80-  
Book value per share (Unadj.) Rs110.516,335.3-  
Shares outstanding (eoy) m111.82332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.73.4 168.0%   
Avg P/E ratio x29.8-10.6 -281.7%  
P/CF ratio (eoy) x22.332.3 68.9%  
Price / Book Value ratio x2.50.8 303.4%  
Dividend payout %53.80-   
Avg Mkt Cap Rs m30,9394,486,134 0.7%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m1,1480-   
Avg. sales/employee Rs Th077,944.8-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,106.1-  
INCOME DATA
Net Sales Rs m5,4061,317,267 0.4%  
Other income Rs m25525,191 1.0%   
Total revenues Rs m5,6611,342,458 0.4%   
Gross profit Rs m1,53434,519 4.4%  
Depreciation Rs m350563,103 0.1%   
Interest Rs m3576,014 0.0%   
Profit before tax Rs m1,404-579,407 -0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,772 0.0%   
Tax Rs m365-7,343 -5.0%   
Profit after tax Rs m1,039-424,292 -0.2%  
Gross profit margin %28.42.6 1,083.0%  
Effective tax rate %26.01.3 2,052.8%   
Net profit margin %19.2-32.2 -59.6%  
BALANCE SHEET DATA
Current assets Rs m7,221540,274 1.3%   
Current liabilities Rs m776477,944 0.2%   
Net working cap to sales %119.24.7 2,519.6%  
Current ratio x9.31.1 823.5%  
Inventory Days Days25520 1,301.1%  
Debtors Days Days6866 102.2%  
Net fixed assets Rs m6,884149,107 4.6%   
Share capital Rs m2240-   
"Free" reserves Rs m12,1270-   
Net worth Rs m12,3515,433,112 0.2%   
Long term debt Rs m781,913,196 0.0%   
Total assets Rs m14,1058,493,191 0.2%  
Interest coverage x41.4-6.6 -624.6%   
Debt to equity ratio x00.4 1.8%  
Sales to assets ratio x0.40.2 247.1%   
Return on assets %7.6-4.1 -185.6%  
Return on equity %8.4-7.8 -107.7%  
Return on capital %11.6-4.8 -239.1%  
Exports to sales %17.30-   
Imports to sales %7.80-   
Net fx Rs m5180-   
CASH FLOW
From Operations Rs m1,404470,610 0.3%  
From Investments Rs m-2,982258,539 -1.2%  
From Financial Activity Rs m-258-807,708 0.0%  
Net Cashflow Rs m-1,709-78,167 2.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.44 Rs / USD

Compare ADVANCED ENZYME TECHNOLOGIES With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ADVANCED ENZYME TECHNOLOGIES With: BHARAT PARENTALS  WALPAR NUTRITIONS LTD.  SHELTER PHARMA  ALEMBIC  DECCAN HEALTH CARE  



Today's Market

Sensex Today Ends 189 Points Lower | IT Stocks Drag | REC Rallies 10%, Hitachi Energy 9% Sensex Today Ends 189 Points Lower | IT Stocks Drag | REC Rallies 10%, Hitachi Energy 9%(Closing)

After opening the day on positive note, Indian share markets reversed the trend as the session progressed and ended lower.